Sensory Network Dysfunction, Behavioral Impairments, and Their Reversibility in an Alzheimer's β-Amyloidosis Mouse Model

被引:111
|
作者
Wesson, Daniel W. [1 ,3 ,7 ,8 ]
Borkowski, Anne H. [8 ]
Landreth, Gary E. [1 ]
Nixon, Ralph A. [4 ,5 ,7 ,9 ]
Levy, Efrat [4 ,6 ,7 ,9 ]
Wilson, Donald A. [2 ,3 ,7 ,8 ]
机构
[1] Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA
[2] NYU, Ctr Neural Studies, New York, NY 10003 USA
[3] NYU, Sch Med, Dept Child & Adolescent Psychiat, New York, NY 10016 USA
[4] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA
[5] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
[6] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA
[7] NYU, Sch Med, Ctr Excellence Brain Aging, New York, NY 10016 USA
[8] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA
[9] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA
来源
JOURNAL OF NEUROSCIENCE | 2011年 / 31卷 / 44期
基金
美国国家卫生研究院;
关键词
FUNCTIONAL CONNECTIVITY; SYNAPTIC PLASTICITY; OLFACTORY SYSTEM; DISEASE; PLAQUES; DEPOSITION; MEMORY; SYNCHRONIZATION; DISRUPTION; MODULATION;
D O I
10.1523/JNEUROSCI.2085-11.2011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The unique vulnerability of the olfactory system to Alzheimer's disease (AD) provides a quintessential translational tool for understanding mechanisms of synaptic dysfunction and pathological progression in the disease. Using the Tg2576 mouse model of beta-amyloidosis, we show that aberrant, hyperactive olfactory network activity begins early in life, before detectable behavioral impairments or comparable hippocampal dysfunction and at a time when amyloid-beta (A beta) deposition is restricted to the olfactory bulb (OB). Hyperactive odor-evoked activity in the piriform cortex (PCX) and increased OB-PCX functional connectivity emerged at a time coinciding with olfactory behavior impairments. This hyperactive activity persisted until later in life when the network converted to a hyporesponsive state. This conversion was A beta-dependent, because liver-X receptor agonist treatment to promote A beta degradation rescued the hyporesponsive state and olfactory behavior. These data lend evidence to a novel working model of olfactory dysfunction in AD and, complimentary to other recent works, suggest that disease-relevant network dysfunction is highly dynamic and region specific, yet with lasting effects on cognition and behavior.
引用
收藏
页码:15962 / 15971
页数:10
相关论文
共 50 条
  • [41] Neuroprotection and improvement of the histopathological and behavioral impairments in a murine Alzheimer's model treated with Zephyranthes carinata alkaloids
    Cortes, Natalie
    Maria Sabogal-Guaqueta, Angelica
    Patricia Cardona-Gomez, Gloria
    Osorio, Edison
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 482 - 492
  • [42] Mechanisms of Neural and Behavioral Dysfunction in Alzheimer's Disease
    Wesson, Daniel W.
    Nixon, Ralph A.
    Levy, Efrat
    Wilson, Donald A.
    [J]. MOLECULAR NEUROBIOLOGY, 2011, 43 (03) : 163 - 179
  • [43] Mechanisms of Neural and Behavioral Dysfunction in Alzheimer’s Disease
    Daniel W. Wesson
    Ralph A. Nixon
    Efrat Levy
    Donald A. Wilson
    [J]. Molecular Neurobiology, 2011, 43
  • [44] Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels
    Pacheco-Quinto, Javier
    de Turco, Elena B. Rodriguez
    DeRosa, Steven
    Howard, Altovise
    Cruz-Sanchez, Felix
    Sambamurti, Kumar
    Refolo, Lorenzo
    Petanceska, Suzana
    Pappolla, Miguel A.
    [J]. NEUROBIOLOGY OF DISEASE, 2006, 22 (03) : 651 - 656
  • [45] Association of aortic atherosclerosis with cerebral β-amyloidosis and learning deficits in a mouse model of Alzheimer's disease
    Li, L
    Cao, DF
    Garber, DW
    Kim, H
    Fukuchi, K
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (06): : 2155 - 2164
  • [46] BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease
    Burke, Rebecca M.
    Norman, Timothy A.
    Haydar, Tarik F.
    Slack, Barbara E.
    Leeman, Susan E.
    Blusztajn, Jan Krzysztof
    Mellott, Tiffany J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (48) : 19567 - 19572
  • [47] Chronic nicotine treatment reduces β-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw)
    Nordberg, A
    Hellström-Lindahl, E
    Lee, M
    Johnson, M
    Mousavi, M
    Hall, R
    Perry, E
    Bednar, I
    Court, J
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 81 (03) : 655 - 658
  • [48] Microglial Response to Increasing Amyloidosis Saturates During Aging of an Alzheimer's Disease Mouse Model
    Brendel, Matthias
    Blume, Tanja
    Focke, Carola
    Peters, Finn
    Deussing, Maximilian
    Beyer, Leonie
    Albert, Nathalie
    Lindner, Simon
    Gildehaus, Franz Josef
    von Ungern-Sternberg, Barbara
    Bartenstein, Peter
    Herms, Jochen
    Rominger, Axel
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [49] False recognition in a mouse model of Alzheimer's disease: rescue with sensory restriction and memantine
    Romberg, Carola
    McTighe, Stephanie M.
    Heath, Christopher J.
    Whitcomb, Daniel J.
    Cho, Kwangwook
    Bussey, Timothy J.
    Saksida, Lisa M.
    [J]. BRAIN, 2012, 135 : 2103 - 2114
  • [50] BEHAVIORAL IMPAIRMENTS RELATED TO COGNITIVE DYSFUNCTION IN THE AUTOIMMUNE NEW-ZEALAND BLACK MOUSE
    SPENCER, DG
    HUMPHRIES, K
    MATHIS, D
    LAL, H
    [J]. BEHAVIORAL NEUROSCIENCE, 1986, 100 (03) : 353 - 358